340borphandrugsolutions

340B Orphan Drug Solutions helps expansion entity hospitals capture orphan drug savings under the 340B program. Founded by Dr. Lisa Nezneski, PharmD, BCPS, the firm brings over 40 years of healthcare experience and more than 11 years of focused orphan drug expertise. Dr. Nezneski has helped hospitals across the country recover over $500 million in orphan drug savings. The firm delivers customised orphan drug portfolios, split-billing software integration, quarterly designation updates, manufacturer discretionary pricing tracking, job aids, and direct specialist support. Every solution is built around the facility's specific case mix, patient population, and existing workflows. Most clients see measurable results within the first quarter.